TerminatedNot applicableNCT02741609
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
Studying Lyme disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Advanced Laboratory Services, Inc.
- Principal Investigator
- Jasbir Arora, PhDAdvanced Laboratory Services
- Intervention
- Borrelia Diagnostic Test(device)
- Enrollment
- 218 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2018
Study locations (16)
- Delaware Integrative Medicine, Georgetown, Delaware, United States
- Penobscot Bay Medical Center, Rockport, Maine, United States
- Infectious Disease/The Research Institute, Springfield, Massachusetts, United States
- Birch Tree Healing Arts, Saint Paul, Minnesota, United States
- Mid Hudson Medical Research, PLLC, New Windsor, New York, United States
- Dr. Steven Bock, MD, Rhinebeck, New York, United States
- Dr. Marina Makous, Exton, Pennsylvania, United States
- Detweiler Family Medicine & Associates, PC, Lansdale, Pennsylvania, United States
- Suburban Research Associates, Media, Pennsylvania, United States
- Cumberland Valley Parochial Medical Clinic, Shippensburg, Pennsylvania, United States
- Lyme Center of New England, Cumberland, Rhode Island, United States
- The Miriam Hospital of Infectious Diseases, Providence, Rhode Island, United States
- Virginia Center for Health & Wellness, Aldie, Virginia, United States
- Rockbridge Traditional Medicine, Lexington, Virginia, United States
- Andrs Wellness Consulting, Petersburg, Virginia, United States
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02741609 on ClinicalTrials.govOther trials for Lyme disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT06785402Ceftriaxone for Post-Treatment Lyme DiseaseHackensack Meridian Health
- RECRUITINGPHASE3NCT07226882A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy AdultsPfizer
- RECRUITINGPHASE4NCT06451913Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))Biocodex
- RECRUITINGNANCT06915324Transcranial Direct Current Stimulation for Post Treatment Lyme DiseaseColumbia University
- RECRUITINGEARLY PHASE1NCT06611111Ceftriaxone Pulse Dose for Post-Treatment Lyme DiseaseState University of New York - Upstate Medical University
- ACTIVE NOT RECRUITINGNCT06835075Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu LatoUniversity Medical Centre Ljubljana
- ACTIVE NOT RECRUITINGNCT06731179A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell AssayViraxBio Labs
- RECRUITINGPHASE1, PHASE2NCT06511050Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue SyndromeIcahn School of Medicine at Mount Sinai